Official registry condition

Extracorporeal Membrane Oxygenation Complication peptide trials

3 selected ClinicalTrials.gov records carrying the official condition label Extracorporeal Membrane Oxygenation Complication. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.

Registry records

3 selected records.

Connected peptides

1 profiles.

Registry update years

2023–2026 in selected records.

Indication intelligence

Selected evidence landscape

Connected profiles1

Exact peptide identities attached to retained registry observations carrying this condition label.

Trial phases3

Phase labels copied from the retained ClinicalTrials.gov versions.

Registry statuses2

Overall statuses at each retained observation, not necessarily current today.

Across the connected peptide profiles, PeptideScanner also carries 30 selected PubMed records and 14 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Extracorporeal Membrane Oxygenation Complication unless their own cited source says so.

Collection change ledger

Recently changed records on this condition hub

All recent changes →

These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.

Record added

ClinicalTrials.gov record NCT03318393

PeptideScanner retained ClinicalTrials.gov record NCT03318393 at 2026-11-15T21:58:19.888Z. Its registry update date was 2023-01-31, and PeptideScanner's reviewed identity mapping was bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
January 31, 2023
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05959252

PeptideScanner retained ClinicalTrials.gov record NCT05959252 at 2026-11-15T21:58:19.888Z. Its registry update date was 2026-05-08, and PeptideScanner's reviewed identity mapping was bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
May 8, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06275555

PeptideScanner retained ClinicalTrials.gov record NCT06275555 at 2026-11-15T21:58:19.888Z. Its registry update date was 2026-04-06, and PeptideScanner's reviewed identity mapping was bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
April 6, 2026
Evidence lane
Clinical trials

Attributed registry records

Selected records

All trial facets →